These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33471400)

  • 41. Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats.
    Ginovart N; Wilson AA; Houle S; Kapur S
    Biol Psychiatry; 2004 Jun; 55(12):1188-94. PubMed ID: 15184038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.
    Boileau I; Guttman M; Rusjan P; Adams JR; Houle S; Tong J; Hornykiewicz O; Furukawa Y; Wilson AA; Kapur S; Kish SJ
    Brain; 2009 May; 132(Pt 5):1366-75. PubMed ID: 19153147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scans.
    Seeman P
    Synapse; 2012 Jan; 66(1):88-93. PubMed ID: 21954082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist.
    Searle G; Beaver JD; Comley RA; Bani M; Tziortzi A; Slifstein M; Mugnaini M; Griffante C; Wilson AA; Merlo-Pich E; Houle S; Gunn R; Rabiner EA; Laruelle M
    Biol Psychiatry; 2010 Aug; 68(4):392-9. PubMed ID: 20599188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.
    Boileau I; Dagher A; Leyton M; Gunn RN; Baker GB; Diksic M; Benkelfat C
    Arch Gen Psychiatry; 2006 Dec; 63(12):1386-95. PubMed ID: 17146013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exploring the relationship between social attachment and dopamine D
    Caravaggio F; Chung JK; Gerretsen P; Fervaha G; Nakajima S; Plitman E; Iwata Y; Wilson A; Graff-Guerrero A
    Soc Neurosci; 2017 Apr; 12(2):163-173. PubMed ID: 26873034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Temporal characterisation of amphetamine-induced dopamine release assessed with [11C]raclopride in anaesthetised rodents.
    Houston GC; Hume SP; Hirani E; Goggi JL; Grasby PM
    Synapse; 2004 Mar; 51(3):206-12. PubMed ID: 14666518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conditioned dopamine release in humans: a positron emission tomography [11C]raclopride study with amphetamine.
    Boileau I; Dagher A; Leyton M; Welfeld K; Booij L; Diksic M; Benkelfat C
    J Neurosci; 2007 Apr; 27(15):3998-4003. PubMed ID: 17428975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography.
    Hartvig P; Torstenson R; Tedroff J; Watanabe Y; Fasth KJ; Bjurling P; Långström B
    J Neural Transm (Vienna); 1997; 104(4-5):329-39. PubMed ID: 9295169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amphetamine-induced striatal dopamine release in schizotypal personality disorder.
    Thompson JL; Rosell DR; Slifstein M; Xu X; Rothstein EG; Modiano YA; Kegeles LS; Koenigsberg HW; New AS; Hazlett EA; McClure MM; Perez-Rodriguez MM; Siever LJ; Abi-Dargham A
    Psychopharmacology (Berl); 2020 Sep; 237(9):2649-2659. PubMed ID: 32572588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
    Payer DE; Guttman M; Kish SJ; Tong J; Strafella A; Zack M; Adams JR; Rusjan P; Houle S; Furukawa Y; Wilson AA; Boileau I
    Mov Disord; 2015 Feb; 30(2):160-6. PubMed ID: 25641350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum.
    Drevets WC; Price JC; Kupfer DJ; Kinahan PE; Lopresti B; Holt D; Mathis C
    Neuropsychopharmacology; 1999 Dec; 21(6):694-709. PubMed ID: 10633475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition.
    Pedersen K; Simonsen M; Østergaard SD; Munk OL; Rosa-Neto P; Olsen AK; Jensen SB; Møller A; Cumming P
    Neuroimage; 2007 Mar; 35(1):38-46. PubMed ID: 17223363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Age-related changes in binding of the D2/3 receptor radioligand [(11)C](+)PHNO in healthy volunteers.
    Matuskey D; Worhunksy P; Correa E; Pittman B; Gallezot JD; Nabulsi N; Ropchan J; Sreeram V; Gudepu R; Gaiser E; Cosgrove K; Ding YS; Potenza MN; Huang Y; Malison RT; Carson RE
    Neuroimage; 2016 Apr; 130():241-247. PubMed ID: 26876475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography study.
    Narendran R; Martinez D; Mason NS; Lopresti BJ; Himes ML; Chen CM; May MA; Price JC; Mathis CA; Frankle WG
    Synapse; 2011 Dec; 65(12):1344-9. PubMed ID: 21780185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopamine D2 receptors mapped in rat brain with [3H](+)PHNO.
    Nobrega JN; Seeman P
    Synapse; 1994 Jul; 17(3):167-72. PubMed ID: 7974199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo binding behavior of dopamine receptor agonist (+)-PD 128907 and implications for the "ceiling effect" in endogenous competition studies with [(11)C]raclopride-a positron emission tomography study in Macaca mulatta.
    Kortekaas R; Maguire RP; Cremers TI; Dijkstra D; van Waarde A; Leenders KL
    J Cereb Blood Flow Metab; 2004 May; 24(5):531-5. PubMed ID: 15129185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heightened Dopaminergic Response to Amphetamine at the D
    Boileau I; Payer D; Rusjan PM; Houle S; Tong J; McCluskey T; Wilson AA; Kish SJ
    Neuropsychopharmacology; 2016 Dec; 41(13):2994-3002. PubMed ID: 27353309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of different cellular environments on PET radioligand binding: an application to D2/3-dopamine receptor imaging.
    Quelch DR; Withey SL; Nutt DJ; Tyacke RJ; Parker CA
    Neuropharmacology; 2014 Oct; 85(100):305-13. PubMed ID: 24910074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat.
    Egerton A; Ahmad R; Hirani E; Grasby PM
    Psychopharmacology (Berl); 2008 Nov; 200(4):487-96. PubMed ID: 18597077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.